Literature DB >> 27243275

Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.

Mauricette Michallet1, Mohamad Sobh1, Hélène Labussière1, Christine Lombard2,3, Fiorenza Barraco1, Mohamed El-Hamri1, Xavier Thomas1, Colette Chapuis-Cellier2,3, Franck E Nicolini1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27243275     DOI： 10.1080/10428194.2016.1185787

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302).

Authors:  Takayoshi Tachibana; Junya Kanda; Shinichiro Machida; Takeshi Saito; Masatsugu Tanaka; Yuho Najima; Satoshi Koyama; Takuya Miyazaki; Eri Yamamoto; Masahiro Takeuchi; Satoshi Morita; Yoshinobu Kanda; Heiwa Kanamori; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2018-01-05       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.